Compounds 1 and 25 moderately prohibited BACE1 (β-secretase 1), an enzyme involved in Alzheimer’s disease pathogenesis, however, the other metabolites had no or weak activity (Figure 4). The gene discussed is BACE1; the disease is Alzheimer disease.